Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 4 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

0
Player Avatar equalfuture (34.28) Submitted: 4/10/2008 4:52:05 AM : Outperform Start Price: $11.74 AMRI Score: -77.61

BUYING AT 5 PER SHARE, stock is valued in my fair value estimates at 5.40 a share i expect movement at this price in late summer.

good company worth 5 or more a share.

Featured Broker Partners


Advertisement